Literature DB >> 19392995

Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?

C Lombardi1, C Incorvaia, M Braga, G Senna, G W Canonica, G Passalacqua.   

Abstract

The modalities of administration of sublingual immunotherapy (SLIT), including dosing, build-up phase, duration of the treatment, and frequency of the maintenance dose are largely variable. In the case of pollen (SLIT), the complexity increases, since preseasonal, coseasonal and pre-coseasonal regimens can be used. The administration regimens are of relevance from a practical point of view, but can also have economic implications. We review herein the available literature (randomized double blind controlled studies) on pollen SLIT, in order to derive experimentally-supported suggestions about the regimens of administration that should be preferred.

Mesh:

Substances:

Year:  2009        PMID: 19392995     DOI: 10.1111/j.1398-9995.2009.02063.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  9 in total

Review 1.  Immunotherapy for allergies and asthma: present and future.

Authors:  Shyam S Mohapatra; Momina Qazi; Gary Hellermann
Journal:  Curr Opin Pharmacol       Date:  2010-06-21       Impact factor: 5.547

Review 2.  Decision-making for pediatric allergy immunotherapy for aeroallergens: a narrative review.

Authors:  Miguel Tortajada-Girbés; María Mesa Del Castillo; Helena Larramona; José Manuel Lucas; Montserrat Álvaro Lozano; Ana Isabel Tabar; Begoña Soler López; Ana Martínez-Cañavate
Journal:  Eur J Pediatr       Date:  2019-08-14       Impact factor: 3.183

3.  [Sublingual immunotherapy. Where are we now?].

Authors:  H Lee; T Zuberbier; M Worm
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

Review 4.  Development of a sublingual allergy vaccine for grass pollinosis.

Authors:  Franco Frati; Silvia Scurati; Paola Puccinelli; Marie David; Cecile Hilaire; Maurizio Capecce; Francesco Marcucci; Cristoforo Incorvaia
Journal:  Drug Des Devel Ther       Date:  2010-07-21       Impact factor: 4.162

5.  Specific immunotherapy by the sublingual route for respiratory allergy.

Authors:  Cristoforo Incorvaia; Simonetta Masieri; Patrizia Berto; Silvia Scurati; Franco Frati
Journal:  Allergy Asthma Clin Immunol       Date:  2010-11-09       Impact factor: 3.406

6.  "The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".

Authors:  Pascal Demoly; Moises A Calderon; Thomas B Casale; Hans-Jørgen Malling; Ulrich Wahn
Journal:  Clin Transl Allergy       Date:  2015-05-04       Impact factor: 5.871

7.  A survey on the perception of allergy specialists about the reimbursed grass pollen tablets for seasonal allergic rhinitis in Italy.

Authors:  Ilaria Massaro; Oliviero Rossi; Cristoforo Incorvaia; Carlo Lombardi
Journal:  Clin Mol Allergy       Date:  2017-08-15

8.  Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper.

Authors:  Giovanni Passalacqua; Enrico Compalati; Giorgio Walter Canonica
Journal:  World Allergy Organ J       Date:  2010-07       Impact factor: 4.084

Review 9.  Recommendations for appropriate sublingual immunotherapy clinical trials.

Authors:  Giovanni Passalacqua
Journal:  World Allergy Organ J       Date:  2014-10-06       Impact factor: 4.084

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.